Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FlavoRx

This article was originally published in The Tan Sheet

Executive Summary

Albertson's Jewel-Osco division now offering OTC and Rx drug flavoring additive in 225 Midwest pharmacies, Melrose Park, Ill. based-firm announces April 4. FlavoRx now sells eponymous product in more than 3,500 pharmacies, including CVS, Giant, Kroger and Pathmark chains, and expects to break 5,000 stores by August. Firm also operates in Canada, U.K., Australia, New Zealand and the Bahamas (1"The Tan Sheet" Nov. 1, 1999, p. 12). FlavoRx plans to continue regionally targeted TV campaigns begun last year and doctor detailing to support brand in new markets

You may also be interested in...



Giant Pharmacies Promoting FlavorRx Program For OTCs

A program enabling consumers to have liquid-based drugs, including OTCs, flavored by pharmacists at Giant Food outlets is being promoted to Washington, D.C.-area consumers. The mid-Atlantic supermarket chain recently ran a full-page ad in the Washington Post publicizing the availability of the FlavorRx program.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel